The same momentum divergence I noted from June 26 to July 10 of 2024 resurfaced again from Jan 15 to 31 of 2025. This is the point where $AQST strongly recovered. The retracement is bit deep than what I would liked but showing higher lows ($2.3 back in mid 2024 vs $3 currently)
The same momentum divergence I noted from June 26 to July 10 of 2024 resurfaced again from Jan 15 to 31 of 2025. This is the point where $AQST strongly recovered. The retracement is bit deep than what I would liked but showing higher lows ($2.3 back in mid 2024 vs $3 currently)
JUST IN: $NBIS AI Studio adds Devstral, the leading open-source LLM for coding agents. 🔥
Nebius AI Studio, the company’s Inference-as-a-Service platform, has just integrated Devstral from Mistral AI — a high-performance, open-source language model optimized for software engineering.
• Ranked 1st on SWE-Bench Verified
• Designed for agentic reasoning and complex codebases
• Supports a 128K-token context window for extended code input
Devstral is now available for instant inference on Nebius AI Studio.
@SunnyMa93127381 I don’t agree with that view. $AQST has float shares of 92 million while its daily trading volume is 1.3 million. It’s the traders that were moving the price at this point while several long term investors are staying put and patient. The thesis remains intact
@mrdizle That is the current sentiment and that’s why now is the best time to load $AQST - without creating too much noise in social media. Long term investing is not for everyone - but has worked well for me.
MESSI HAS MADE ME SPEECHLESS… THIS HAS TO BE THE GREATEST CARRY JOB IN THE HISTORY OF FOOTBALL NO PLAYER CAN DO WHAT MESSI IS DOING FOR INTER MIAMI
#messi#intermiami#GOAT#FIFACWC#porto
@StarbeamInvest I’ve been here in this stock for a long time. I’ve seen ups and downs. Long term investors don’t worry as much as traders. All I see is continued derisking. $AQST upside remains massive. Thesis remains on track. Nothing fundamentally changed. You’re having fun reminding me lol
@dansfera looks like our friend blocked me and also called me a day trader. $AQST long. He probably got annoyed when I advised him to slow down because it might sound to some that he was pumping the stock (I don’t think he does but it might look that way to some folks)
Aquestive Therapeutics Announces FDA Acceptance of New Drug Application and PDUFA Date for Anaphylm™ for the Treatment of Severe Allergic Reactions $AQST https://t.co/5VVptCXm8E